leisure time -WSS

leisure time

author：focus 2025-09-05 11:25:51 - browse：4143

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Let's speed up science by embracing open access publishing

leisure time

WSS

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

CDC director unscathed in first congressional testimony

Rep. Raul Ruiz on the physician shortage and more

Organ aging and disease risk measured by new blood test

NIH documents show early flaws of $1.6 billion long Covid program

Wikipedia

leisure time

focus

Tori Bowie and the unacceptable rates of Black maternal death

Takeda, Janssen join wearable maker to measure scratching

Medicare proposal to cover medical devices draws a mixed reaction

At ASCO, AstraZeneca reports strong data for breast cancer drug

BioMarin wins approval for gene therapy to treat hemophilia A

Let's speed up science by embracing open access publishing

Continuity nursing helped my family in our darkest PICU moments

The EPA's new lead rule: How one expert crunched the numbers

How to save PrEP access — and even expand it

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

hotspot

Cigna, Humana reportedly in talks to merge

As biotech industry slumps, bioscience job market is upside down

BIO selects John Crowley as new CEO

ReNAgade cuts staff seven months after raising $300 million

Let's speed up science by embracing open access publishing

What to do when lifesaving products contribute to climate change

hotspot

leisure time

focus

knowledge